ArticleCureus2026
Rasch Analysis of the Composite Autonomic Symptom Score (COMPASS-31) From Data Collected in an Online Population.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA Dutch internet panel with volunteers was assessed using the patient-reported outcome measure known as the Composite Autonomic Symptom Score (COMPASS-31).
objectivesThis study aimed to analyze the Dutch version of the COMPASS-31 using classical test theory and Rasch analysis, or one-parameter item response theory, to examine the questionnaire's structure for the second time in a different population. The first group consisted of clinical patients, while the second group consisted of the general population. The choice of the general population contrasts with most validation studies, which focus on clinical groups, as in our first study.
methodsA transversal observational study of a cohort of 100 people voluntarily completed the Dutch version of the COMPASS-31 online. The sample population comprised 100 persons (42 females, 58 males). The age groups and their percentages were as follows: 18-29 years, 37%; 30-44 years, 22%; 45-60 years, 31%; and over 60 years, 10%. Classical test theory was performed after importing the data into IBM SPSS Statistics for Windows, Version 31.0 (IBM Corp., Armonk, New York, United States). Six Rasch analyses were completed for each domain of the COMPASS-31 using the Winsteps measurement software (Winsteps Rasch Measurement Version 5.10.0).
resultsThe COMPASS-31 domains performed moderately in a group of adult volunteers. Cronbach's alpha across the domains was below 0.65, except for the Gastrointestinal, Bladder, and Pupillomotor domains, which were 0.65 or above. The person's reliability is below 0.8, the minimum level required for serious decision-making. Item reliability was good, except for the Bladder domain, which had a reliability of zero. Only the Pupillomotor domain can differentiate between the two population groups. Not all items in the Vasomotor and Gastrointestinal domains measure a single unidimensional variable, one of the prerequisites for a Rasch model. The probability curve for different domains performed adequately. Patients were able to distinguish between four levels of items. Some domains included categories that were too broad.
conclusionThis study, conducted with a different group of internet volunteers, offered several valuable insights into the psychometric properties of the COMPASS-31 and its domains. Our data again did not align with the Rasch model. The analysis failed to confirm the scale's reliability, as the domains could differentiate only one or two levels of autonomic symptoms in adults. The person's reliability is below 0.8, which is the minimum threshold needed for meaningful decision-making. Only the Pupillomotor domain can distinguish between the two groups, while the other domains identify only one of them. The COMPASS-31 is a screening tool or descriptive profile, not a unidimensional measure designed to produce a single, interval-level score for any domain. Based on our findings, we recommend against using the total score as a single metric. The domains should serve as independent, ordinal indices. Item banks for computer adaptive testing (CAT) should be developed specifically for each domain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.